REED ELIZABETH E bought TVTX
September 22, 2025 · Form 4 insider transaction
REED ELIZABETH E bought 10,000 shares of Travere Therapeutics, Inc. at $19.08 per share, a transaction worth $190.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$19.08
Total value
$190.8K
InsiderREED ELIZABETH E
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 22, 2025
Filing dateSeptember 24, 2025
Shares owned after99,878
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 396 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 31, 2025.